# Helus Pharma (HELP) — News

HELP · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/help/news

## Recent headlines

- [Helus Pharma appoints Dr. Suresh Durgam to board of directors](https://www.ainvest.com/news/helus-pharma-appoints-dr-suresh-durgam-board-directors-2610) — AInvest Wire, Oct 15, 2026
- [Aequs signs long-term supply pacts with Safran](https://www.ainvest.com/news/aequs-signs-long-term-supply-pacts-safran-2610) — AInvest Wire, Oct 12, 2026
- [Cilo Cybin - Dr Tham Seng Kong disposes beneficial interest, now holds 9.17% in Cilo Cybin](https://www.ainvest.com/news/cilo-cybin-dr-tham-seng-kong-disposes-beneficial-interest-holds-9-17-cilo-cybin-2610) — AInvest Wire, Oct 1, 2026
  Cilo Cybin Holdings Limited (CCC) has announced that Dr Tham Seng Kong, a non-executive director of the company, has disposed of his beneficial interest in the business. As a result, Dr Tham now holds 9.17% of the issued share capital , down from his previous holding of 10%. This development…
- [Cilo Cybin - Tan Sri Dato' Lim Kuang Sia holds 12.48% beneficial interest in Cilo Cybin](https://www.ainvest.com/news/cilo-cybin-tan-sri-dato-lim-kuang-sia-holds-12-48-beneficial-interest-cilo-cybin-2610) — AInvest Wire, Oct 1, 2026
  Tan Sri Dato' Lim Kuang Sia holds a 12.48% beneficial interest in Cilo Cybin, according to available records. This stake positions him as a significant shareholder in the company, potentially influencing corporate governance and strategic decisions. Shareholding structures of this nature are often…
- [Helus Pharma appoints Michael Halstead as chief executive officer](https://www.ainvest.com/news/helus-pharma-appoints-michael-halstead-chief-executive-officer-2608) — AInvest Wire, Aug 3, 2026
  Helus Pharma (Nasdaq: HELP) has announced the appointment of Michael Cola as Chief Executive Officer, effective immediately . Cola brings over 30 years of experience in neuroscience, rare disease, and specialty pharmaceuticals, including leadership roles at Shire PLC, Astra-Merck, and AstraZeneca…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).